VICTOR, New York, December 18 /PRNewswire/ --

Kirtas Technologies, the leader in quality, high-speed book digitization, and LexisNexis, a leading provider of information services to professionals in the legal, risk management, corporate, government and academic markets, today announced LexisNexis will join the growing number of organizations utilizing the Kirtas solution for mass digitization of printed materials.

OAK PARK, Michigan, December 18 /PRNewswire/ -- Azure Dynamics Corporation (TSX: AZD & LSE: ADC) ("Azure" or the "Company"), a leading developer of hybrid electric and electric powertrains for commercial vehicles is pleased to announce it has signed a commercial development and cooperation agreement with Florida Power and Light ("FPL"), a wholly owned subsidiary of FPL Group (NYSE: FPL). Azure will deliver a gasoline parallel hybrid electric Ford E-450 based vehicle for industry viability validation, testing and demonstration within the FPL fleet.

ZAANDAM, Netherlands, December 18 /PRNewswire/ --

WoodWing Software has been selected by UK publisher Express Newspapers to supply Smart Connection Enterprise as the editorial platform for the Daily Express, Daily Star, Ok! Magazine and several other publications.

With an average daily sale approaching two million copies, Express Newspapers is one of the largest newspaper publishing companies in the UK. After carefully evaluating the main suppliers of editorial solutions, the company decided to replace its existing QPS system with WoodWing's Smart Connection Enterprise. At 700 seats, this is one of the larger members of the WoodWing family.

SHANGHAI, December 18 /PRNewswire/ -- CBI China (http://www.cbichina.com), C1 Energy (http://www.c1energy.net/), Shanghai Petroleum Exchange Ltd, and Galaxy Merchandise Exchange (GEMEX) will hold a press briefing in Beijing to sign agreements covering future collaboration between the four companies.

Two collaboration agreements will be signed in the ceremony. The first will be a merger agreement between CBI China and C1 Energy.

SAN FRANCISCO and LONDON, December 18 /PRNewswire/ --

- Acquisitions include one fully leased property and one value-add redevelopment opportunity, bringing the European portfolio to over 1 million square feet

INCHEON, South Korea, December 18 /PRNewswire/ --

Celltrion, Inc., a leading Korean biopharmaceutical company, announces that it has received approval from the U.S. Food and Drug Administration (FDA) to serve as a contract manufacturer to produce ORENCIA(R) (abatacept), a novel biologic agent for the treatment of rheumatoid arthritis, developed by Bristol-Myers Squibb Company (NYSE: BMY). The Supplemental Biological License Application (sBLA) was submitted by Bristol-Myers Squibb Company to meet expected long-term demand for ORENCIA(R).

Celltrion is the largest biopharmaceutical manufacturing facility in the Asia-Pacific region, and the only Asian large-scale cell-culture contract manufacturing facility which has successfully obtained approval from the U.S. FDA.